Pregnancy, Delivery, and Neonatal Outcomes in Subjects with Ongoing Pregnancies Established During Study NT-03

Investigator: Mary Norton, MD
Sponsor: Nora Therapeutics, Inc.

Location(s): United States


The purpose of this study is to evaluate pregnancy, delivery, and neonatal outcomes in subjects who maintain ongoing clinical pregnancies through Week 10 of gestation in NT-03 ( Thrive-IVF Research Study).